People: Derma Sciences Inc (DSCI.OQ)

DSCI.OQ on NASDAQ Stock Exchange Capital Market

8.44USD
26 Nov 2014
Price Change (% chg)

$0.14 (+1.69%)
Prev Close
$8.30
Open
$8.30
Day's High
$8.50
Day's Low
$8.23
Volume
20,184
Avg. Vol
24,689
52-wk High
$15.50
52-wk Low
$7.89

Search Stocks

Summary

Name Age Since Current Position

Edward Quilty

63 1996 Chairman of the Board, President, Chief Executive Officer

John Yetter

61 2013 Chief Financial Officer, Executive Vice President - Finance

Robert Cole

61 2013 Group President - Traditional Wound Care and Corporate Accounts

Barry Wolfenson

47 2013 Group President - Advanced Wound Care and Pharmaceutical Development

Frederic Eigner

64 2005 Executive Vice President - Operations; General Manager of Derma Sciences Canada, Inc.

Bruce Wesson

71 2008 Vice Independent Lead Director

Stephen Wills

57 2008 Lead Independent Director

Srini Conjeevaram

55 1998 Independent Director

Brett Hewlett

51 2010 Independent Director

Robert Moussa

67 2005 Independent Director

Amy Paul

62 2013 Independent Director

C. Richard Stafford

78 2002 Independent Director

Kim Golodetz

IR Contact Officer

Biographies

Name Description

Edward Quilty

Mr. Edward J. Quilty serves as Chairman of the Board, President, Chief Executive Officer of Derma Sciences Inc. He has served as Chief Executive Officer since November, 1996, Chairman of the Board since May, 1996 and as a director since March, 1996. Mr. Quilty was the Chairman of the Board of Palatin Technologies, Inc., a publicly traded biopharmaceutical company specializing in peptide drug design for diagnostic and therapeutic agents, from November 1995 until May 2000. During the period November 1998 through May 2000, Mr. Quilty held the Chief Executive Officer positions at both Derma Sciences and Palatin Technologies, Inc. From July 1994 through November 1995, he was President and Chief Executive Officer of MedChem Products, Inc., a publicly traded developer and manufacturer of specialty medical products which was acquired by C. R. Bard in November 1995. From March 1992 through July 1994, Mr. Quilty served as President and Chief Executive Officer of Life Medical Sciences, Inc., a publicly traded developer and manufacturer of specialty medical products including wound healing agents. The assets of Life Medical Sciences were purchased by MedChem Products, Inc. During the period January 1987 through September 1991 Mr. Quilty served as Vice President — Sales and Marketing and later as Executive Vice President (in which capacity he shared the office of the President) with McGaw Laboratories, a pharmaceutical and medical device company. Previously, he served from 1974 in a variety of sales, marketing and management positions with Baxter/American Hospital Supply Corporation. Mr. Quilty has over 35 years of experience in the healthcare industry primarily in strategic planning, management and sales and marketing. He earned a Bachelor of Science degree from Missouri State University, Springfield, Missouri in 1973 and a Master of Business Administration degree from Ohio University, Athens, Ohio in 1987.

John Yetter

Mr. John E. Yetter, CPA, serves as Chief Financial Officer, Executive Vice President - Finance of Derma Sciences Inc., since January 1, 2013, and previously, as the Vice President and Chief Financial Officer beginning in August 2000. Prior to joining the company, Mr. Yetter held a variety of senior financial positions with Bristol-Myers Squibb Company. Before his association with Bristol-Myers Squibb, he held several supervisory financial positions with Cooper Industries, Inc., Price Waterhouse and Hulse Manufacturing Company. Mr. Yetter is a member of the American Institute of Certified Public Accountants and the New York Society of Certified Public Accountants. He earned a Bachelor of Science in Accounting, magna cum laude, from Boston College School of Management, Boston, Massachusetts in 1975.

Robert Cole

Mr. Robert C. Cole serves as Group President - Traditional Wound Care and Corporate Accounts of Derma Sciences Inc., since January 1, 2013, and previously as the Executive Vice President for Sales beginning in May 2006. Prior to his position as Executive Vice President for Sales he served as the Vice President — Sales and Marketing from January 2003 through April 2006. Prior to joining the company, Mr. Cole held a variety of executive sales positions with B. Braun Medical and predecessor firms beginning in 1974, most recently as Vice President, Sales, Eastern Zone. Mr. Cole earned his Bachelor of Science degree in Biology, cum laude, from St. Vincent’s College, Latrobe, Pennsylvania, in 1974.

Barry Wolfenson

Mr. Barry J. Wolfenson serves as Group President - Advanced Wound Care and Pharmaceutical Development of Derma Sciences Inc., since January 1, 2013. Mr. Wolfenson previously served as the Executive Vice President, Global Business Development and Marketing from March 2010 through December 2012; the Vice President for Marketing and Business Development from March 2006 through February 2010; and the Director of Marketing from February 2004 through February 2006. Prior to joining the company, Mr. Wolfenson held a variety of sales and marketing positions with Bristol-Myers Squibb beginning in 2001, most recently as Marketing Manager with the Bristol-Myers Squibb ConvaTec division. Before his association with Bristol-Myers Squibb, he operated a entrepreneurial venture and served as an account executive with Andersen Consulting. Mr. Wolfenson earned a Bachelor of Science degree in Economics from Franklin and Marshall College, Lancaster, Pennsylvania, in 1989 and a Master of Business Administration degree, cum laude (Phi Beta Kappa) from the University of Michigan, Ann Arbor, Michigan, in 2001.

Frederic Eigner

Mr. Frederic Eigner serves as Executive Vice President - Operations of Derma Sciences Inc., and General Manager of the Company’s Canadian subsidiary, Derma Sciences Canada Inc., since March, 2005. Previously, beginning in August 2002, he served as Vice President for Operations of Derma Sciences Canada Inc. Prior to its acquisition by the company, he held several positions with Dumex Medical Inc. during the period 1992 until August 2002, most recently as Executive Vice President. Prior to his association with Dumex Medical Inc., Mr. Eigner held a variety of executive manufacturing positions with The Kendall Company during the period 1980 through 1992, most recently as Director of Manufacturing. He earned a Bachelor of Science degree in Industrial Engineering from the High Technical School of Kranj, Slovenia, in 1975, a Master of Science degree in Chemical Engineering from the University of Maribor, Slovenia, in 1980, and a Master of Business Administration degree from the University of Toronto, Ontario, Canada, in 2000.

Bruce Wesson

Mr. Bruce F. Wesson serves as Vice Independent Lead Director of Derma Sciences Inc. He has served as vice lead director and a director of Derma Sciences since July 2008 and May 2006, respectively. He is a founder and a General Partner of Galen Partners, L.P., a health care venture capital firm, and presently serves as its Senior Advisor. Prior to founding Galen Partners, L.P., Mr. Wesson served for over twenty three years with the Corporate Finance Division of Smith Barney, Harris Upham & Co. Inc., most recently as Senior Vice President and Managing Director. He also chaired Smith Barney’s Valuation and Opinion Committee in which capacity he maintained responsibility for the firm’s valuations and fairness opinions. Mr. Wesson currently serves as a director and is a member of the Compensation Committee and the Audit Committee of Acura Pharmaceuticals, Inc., a specialty pharmaceutical company. He also serves as Vice Chairman, director and Chairman of the Audit Committee of MedAssets, Inc., a provider of technology-enabled products and services to the healthcare industry, and serves as a director of several of Galen Partners, L.P.’s private portfolio companies. Mr. Wesson earned a Bachelor of Arts degree from Colgate University, Hamilton, New York, in 1964 and a Master of Business Administration degree from Columbia University, New York, New York, in 1967.

Stephen Wills

Mr. Stephen T. Wills, CPA, MST., serves as Lead Independent Director of Derma Sciences Inc. He has served as lead director and a director of Derma Sciences since July 2008 and May 2000, respectively. He also served as the Chief Financial Officer from July 1997 and Vice President from November 1997 until his resignation from these positions in July 2000. Mr. Wills currently serves as Executive Vice President, Chief Financial Officer and Chief Operating Officer of Palatin Technologies, Inc., a publicly traded biopharmaceutical company. Mr. Wills currently serves as a director and audit chairman for Miami International Holdings, LLC, a development stage option trading exchange company located in Princeton, New Jersey. Mr. Wills is a member of the American Institute of Certified Public Accountants, New Jersey Society of Certified Public Accountants and Pennsylvania Institute of Certified Public Accountants. He earned a Bachelor of Science degree in Accounting from West Chester University, West Chester, Pennsylvania in 1979 and a Master of Science in Taxation from Temple University, Philadelphia, Pennsylvania in 1994.

Srini Conjeevaram

Mr. Srini Conjeevaram serves as an Independent Director of Derma Sciences Inc., since May 1998. Mr. Conjeevaram is Managing Director of SC Capital Management, LLC pursuing growth equity opportunities in healthcare. Mr. Conjeevaram is also the general partner of growth equity funds with investments in several privately-held healthcare companies. From 1991 through March 2006, he was with Galen Associates, focusing on growth equity healthcare investments, becoming a General Partner in 1996. Prior to his affiliation with Galen Associates, he was an Associate in Corporate Finance at Smith Barney from 1989 to 1990 and a Senior Project Engineer for General Motors Corporation from 1982 to 1987. Mr. Conjeevaram earned a Bachelor of Science degree in Mechanical Engineering from Chennai University, Chennai, India, a Master of Science degree in Mechanical Engineering from Stanford University, Stanford, California, and a Master of Business Administration from Indiana University, Bloomington, Indiana.

Brett Hewlett

Mr. Brett D. Hewlett serves as an Independent Director of Derma Sciences Inc., since February 18, 2010. Mr. Hewlett has served since 2005 as the Chief Executive Officer of Comvita Limited (“Comivta”), a publicly listed natural products and life sciences company headquartered in New Zealand (NZSX:CVT). Prior to his affiliation with Comvita, Mr. Hewlett served for fifteen years with Tetra Pak, a food packaging company, in the capacities of Managing Director for Eastern Mediterranean markets and Commercial Director for Saudi Arabia. He has organized and managed his own consulting company and has been an active angel investor supporting start-up companies in New Zealand. Mr. Hewlett earned a Bachelor of Food Technology degree from Massey University, New Zealand, in 1987 and a Masters of Business Administration degree from International Institute for Management Development, Switzerland, in 1993.

Robert Moussa

Mr. Robert G. Moussa serves as an Independent Director of Derma Sciences Inc., since May 2005. Mr. Moussa is the Chairman, President and Chief Executive Officer of Dilon Technologies, Inc., makers of a gamma imaging system for early breast cancer detection, a position he has held since February 2008. Before joining Dilon Technologies, Inc., Mr. Moussa served as President and Chief Executive Officer of Robert Moussa & Associates, a consulting firm serving the pharmaceutical, biotechnology and healthcare industries. Prior to founding this firm, he served in a variety of executive positions with Mallinckrodt, Inc., St. Louis, Missouri, healthcare and chemical company. Mr. Moussa’s most recent assignment at Mallinckrodt, Inc. was President – International, a position he held from 1995 through 1997. Previously he served from 1992 to 1996 as President and Chief Executive Officer of Mallinckrodt Medical, Inc., Mallinckrodt, Inc.’s business unit. Before joining Mallinckrodt Medical, Inc., Mr. Moussa served during the period 1978 through 1992 as Mallinckrodt, Inc.’s Group Vice President — International Medical Products, Vice President and General Manager — Medical Products Europe, General Manager — Critical Care, Director of Business Operations and General Sales Manager. Prior to joining Mallinckrodt, Inc., Mr. Moussa held a number of positions during the period from 1969 through 1976 with Sherwood Medical, United Kingdom, most recently as Director of Marketing. Mr. Moussa received his Baccalaureate from the Collége du Sacre-Cœur, Beirut, Lebanon, in 1966 and his Bachelor of Science in Business Administration from Ealing University, London, England, in 1969. He has also completed executive seminars at the University of California at Berkeley, the Aspen Institute, the Wharton Executive School and the Center for Creative Leadership.

Amy Paul

Ms. Amy S. Paul is an Independent Director of Derma Sciences, Inc., since May 2013. Ms. Paul retired in 2008 following a 26-year career with C.R. Bard, Inc., a medical device company, most recently serving as the Group Vice President-International since 2003. She served in various positions at C.R. Bard, Inc. from 1982 to 2003, including President of Bard Access Systems, Inc., President of Bard Endoscopic Technologies, Vice President and Business Manager of Bard Ventures, Vice President of Marketing of Bard Cardiopulmonary Division, Marketing Manager for Davol Inc., and Senior Product Manager for Davol Inc. Ms. Paul was a director of Viking Systems, Inc., a publicly traded company, until October 2012 when it was acquired by Conmed Corporation, was a commissioner of the Northwest Commission on Colleges and Universities from 2010 through 2013, and was a Director of Theraclion from 2010 through 2012, a privately held company in Paris, France. Ms. Paul currently serves on the President’s Innovation Network at Westminster College and is a Director of Wright Medical Technologies, a publicly traded company, for which she chairs the Nominating, Governance and Compliance Committee. Ms. Paul earned a Bachelor of Arts degree in English from Boston University in 1973 and an MBA from Boston University in 1978.

C. Richard Stafford

Mr. C. Richard Stafford, Esq., serves as an Independent Director of Derma Sciences Inc., since May 2002. Mr. Stafford is a consultant to the pharmaceutical industry. Previously, he was Vice President for Corporate Development and a member of the operating committee of Carter-Wallace, Inc., a multinational manufacturer of pharmaceutical, toiletry and diagnostic products. Prior to joining Carter-Wallace, Inc. in 1977, Mr. Stafford was President of Caithness Corporation, a natural resources development firm, and an adjunct professor of law at New York University Law School. Mr. Stafford earned his Bachelor of Arts, cum laude, from Harvard College, his Bachelor of Laws from Harvard Law School and his Master of Laws from New York University Law School.

Kim Golodetz

Basic Compensation

Name Fiscal Year Total

Edward Quilty

1,217,280

John Yetter

605,688

Robert Cole

592,149

Barry Wolfenson

718,035

Frederic Eigner

592,833

Bruce Wesson

--

Stephen Wills

70,125

Srini Conjeevaram

--

Brett Hewlett

--

Robert Moussa

--

Amy Paul

--

C. Richard Stafford

--

Kim Golodetz

--
As Of 30 Dec 2013

Options Compensation

Name Options Value

Edward Quilty

810,805 65,363

John Yetter

414,000 32,513

Robert Cole

405,000 17,363

Barry Wolfenson

120,000 2,500

Frederic Eigner

276,375 6,094

Bruce Wesson

0 0

Stephen Wills

47,000 0

Srini Conjeevaram

0 0

Brett Hewlett

0 0

Robert Moussa

0 0

Amy Paul

0 0

C. Richard Stafford

0 0

Kim Golodetz

0 0
Search Stocks